Evidence map›Paper›PMID 28052771›Full record

SynthesisBMC health services research2017

Performance-based financing for improving HIV/AIDS service delivery: a systematic review.

Amitabh B Suthar, Jason M Nagata, Sabin Nsanzimana, Till Bärnighausen, Eyerusalem K Negussie, Meg C Doherty

Abstract readSystematic Review
In one paragraph

Synthesis in BMC health services research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Amitabh B SutharDepartment of HIV/AIDS, World Health Organization, 20 Avenue Appia, CH-1211, Geneva 27, Switzerland. amitabh.suthar@gmail.com.
Jason M NagataDepartment of Pediatrics, Stanford University School of Medicine, Stanford, USA.
Sabin NsanzimanaRwanda Biomedical Center, Kigali, Rwanda.
Till BärnighausenInstitute of Public Health, Faculty of Medicine, Heidelberg University, Heidelberg, Germany.
Eyerusalem K NegussieDepartment of HIV/AIDS, World Health Organization, 20 Avenue Appia, CH-1211, Geneva 27, Switzerland.
Meg C DohertyDepartment of HIV/AIDS, World Health Organization, 20 Avenue Appia, CH-1211, Geneva 27, Switzerland.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundAlthough domestic HIV/AIDS financing is increasing, international HIV/AIDS financing has plateaued. Providing incentives for the health system (i.e. performance-based financing [PBF]) may help countries achieve more with available resources. We systematically reviewed effects of PBF on HIV/AIDS service delivery to inform WHO guidelines.

methodsPubMed, WHO Index Medicus, conference databases, and clinical trial registries were searched in April 2015 for randomised trials, comparative contemporaneous studies, or time-series studies. Studies evaluating PBF in people with HIV were included when they reported service quality, access, or cost. Meta-analyses were not possible due to limited data. This study is registered with PROSPERO, number CRD42015023207.

resultsFour studies, published from 2009 to 2015 and including 173,262 people, met the eligibility criteria. All studies were from Sub-Saharan Africa. PBF did not improve individual testing coverage (relative risk [RR], 1.00, 95% confidence interval [CI] 0.89 to 1.13), improved couples testing coverage (RR 1.11, 95% CI 1.02 to 1.20), and improved pregnant women testing coverage (RR 1.29, 95% CI 1.28-1.30). PBF improved coverage of antiretrovirals in pregnant women (RR 1.55, 95% CI 1.50 to 1.59), infants (RR 1.92, 95% CI 1.84 to 2.01), and adults (RR 1.74, 1.64 to 1.85). PBF reduced attrition (RR 0.84, 95% CI 0.74 to 0.96) and treatment failure (odds ratio 0.55, 95% CI 0.32 to 0.97). Potential harms were not reported.

conclusionsAlthough the limited data suggests PBF positively affected HIV service access and quality, critical health system and governance knowledge gaps remain. More research is needed to inform national policymaking.

Indexed as

Acquired Immunodeficiency SyndromeAdultAfrica South of the SaharaAnti-HIV AgentsCommunicable Disease ControlDelivery of Health CareFemaleFinancing, OrganizedHealth Services AccessibilityHIV InfectionsHumansPregnancyRandomized Controlled Trials as TopicReimbursement, IncentiveUniversal Health InsuranceAnti-HIV AgentsAccessAIDSAntiretroviral therapyEfficiencyHealth financingHIVHIV testingHIV treatmentQualityServiceUniversal health coverage

Identifiers

PMID28052771
PMCPMC5210258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.